Status:
COMPLETED
Clinical and Radiological Outcomes Following Insertion of a Novel Removable Percutaneous Interspinous Process Spacer: an Initial Experience.
Lead Sponsor:
Centre Hospitalier Universitaire de Nice
Conditions:
Degenerative Lumbar Spinal Stenosis
Neurologic Intermittent Claudication
Eligibility:
All Genders
18+ years
Brief Summary
Purpose To evaluate clinical and radiologic outcome of a series of patients treated with a removable percutaneous interspinous process spacer (IPS) (LobsterProject® Techlamed®) for symptomatic degener...
Eligibility Criteria
Inclusion
- removable percutaneous IPS treatment
- attended interventional radiology outpatient consultations for back pain and NIC, refractory to medical treatment
Exclusion
- PS positioning included cauda equina syndrome
- permanent motor deficit,
- previous spine surgery,
- spondylolisthesis greater than Meyerding grade I,
- local or systemic infection and severe osteoarthritis with pronounced osteophytosis or bone bridges
Key Trial Info
Start Date :
January 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 21 2021
Estimated Enrollment :
59 Patients enrolled
Trial Details
Trial ID
NCT05203666
Start Date
January 1 2021
End Date
October 21 2021
Last Update
January 24 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Nice University Hospital
Nice, France, 06000